COMMISSION IMPLEMENTING DECISION (EU) 2026/190

| Official Journal of the European Union | EN L series ---|---|--- * * * | 2026/190 | 26.1.2026 ---|---|--- COMMISSION IMPLEMENTING DECISION (EU) 2026/190 of 21 January 2026 amending the Annexes to Implementing Decision (EU) 2025/1582 concerning certain emergency measures relating to infection with lumpy skin disease virus in Italy (notified under document C (2026) 459) (Only the Italian text is authentic) (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (1), and in particular Article 259(1) thereof, Whereas: (1) | Infection with lumpy skin disease virus is an infectious, vector-borne disease affecting bovine animals. Its occurrence can have a severe impact on the concerned animal population and on the profitability of farming, also causing disturbance to movements of those animals and products thereof within the Union and exports to third countries. In the event of an outbreak of an infection with lumpy skin disease virus in bovine animals, there is a serious risk of the spread of that disease to other establishments keeping bovine animals, particularly due its main mode of transmission through vectors. ---|--- (2) | Commission Delegated Regulation (EU) 2020/687 (2) supplements the rules for the control of the listed diseases referred to in Article 9(1), points (a), (b) and (c), of Regulation (EU) 2016/429, and defined as category A, B and C diseases in Commission Implementing Regulation (EU) 2018/1882 (3). In particular, Articles 21 and 22 of Delegated Regulation (EU) 2020/687 provide for the establishment of a restricted zone in the event of an outbreak of a category A disease, including infection with lumpy skin disease virus, and for certain measures to be applied therein. In addition, Article 21(1) of that Delegated Regulation provides that the restricted zone is to comprise at least a protection zone, a surveillance zone, and, if necessary, further restricted zones around or adjacent to the protection and surveillance zones. ---|--- (3) | Commission Implementing Decision (EU) 2025/1582 (4) lays down certain emergency measures related to outbreaks of infection with lumpy skin disease virus in Italy. Article 1 of Implementing Decision (EU) 2025/1582 provides for the establishment, in Italy, of restricted zones, comprising protection and surveillance zones, in accordance with Article 21 of Delegated Regulation (EU) 2020/687, as well as the establishment of vaccination zones, in accordance with Part 1 of Annex IX to Commission Delegated Regulation (EU) 2023/361 (5). In addition, Article 1 of Implementing Decision 2025/1582 provides that those protection and surveillance zones, as well as the vaccination zones, are to comprise at least the areas listed in Annexes I and II thereto, and the measures required to be applied in those zones are to be applied at least until the dates set out in those Annexes. ---|--- (4) | Since the last amendment of Implementing Decision (EU) 2025/1582 by Commission Implementing Decision (EU) 2025/2424 (6), no additional outbreaks of infection with lumpy skin disease virus in establishments keeping bovine animals have been notified in Italy. ---|--- (5) | In addition, on 12 January 2026, Italy informed the Commission of the completion of eradication measures for all outbreaks of infection with lumpy skin disease virus in establishments keeping bovine animals in the provinces of Nuoro and Oristano, in the region of Sardinia. Consequently, the duration of the protection and surveillance zones established around those outbreaks should be updated and set out in Annex I to that Implementing Decision. ---|--- (6) | The size of the areas indicated as protection and surveillance zones in Annex I to Implementing Decision (EU) 2025/1582, as amended by this Decision, as well as the duration of the measures to be applied therein, are based on the criteria laid down in Article 64(1) of Regulation (EU) 2016/429, as well as on the rules laid down in Delegated Regulation (EU) 2020/687. The criteria applied for the choice of the size of the protection and surveillance zones, as well as of the duration of the measures to be applied therein, include the consideration of not only the epidemiological situation as regards infection with lumpy skin disease virus in the areas affected by that disease, but also of other epidemiological factors, including geographical parameters and the risk for the further spread of the disease in view of the presence of insect vectors. The chosen duration of the measures provided for in this Decision has also taken into account the international standards of the Terrestrial Animal Health Code of the World Organisation for Animal Health (7). ---|--- (7) | Articles 2 of Implementing Decision (EU) 2025/1582 prohibits the movements of bovine animals from the protection and surveillance zones set out in Annex I to that Implementing Decision to destinations outside the external perimeter of those zones in Italy or outside that Member State until the dates listed in that Annex. In view of the currently existing restricted zone in the region of Sardinia, that prohibition should continue to apply in the protection and surveillance zones established in Implementing Decision (EU) 2025/1582, as amended by this Decision. ---|--- (8) | The vaccination zones established in Implementing Decision (EU) 2025/1582 remain necessary, and vaccination should continue in accordance with Italy’s official vaccination plan dated 1 July 2025, which was submitted pursuant to Article 6(4), point (a), of Delegated Regulation (EU) 2023/361. ---|--- (9) | The Annexes to Implementing Decision (EU) 2025/1582 should, therefore, be amended accordingly. ---|--- (10) | In light of the epidemiological situation in Italy, the amendments to be made to Implementing Decision (EU) 2025/1582 by this Decision should apply as soon as possible, to prevent the further spread of the disease within Italy, to other Member States or to third countries, and to avoid any unnecessary disturbance to trade within the Union or unjustified barriers to trade with third countries. ---|--- (11) | The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, ---|--- HAS ADOPTED THIS DECISION: Article 1 The Annexes to Implementing Decision (EU) 2025/1582 are replaced by the text set out in the Annex to this Decision. Article 2 This Decision is addressed to the Italian Republic. Done at Brussels, 21 January 2026. For the Commission Olivér VÁRHELYI Member of the Commission * * * (1) OJ L 84, 31.3.2016, p. 1, ELI: http://data.europa.eu/eli/reg/2016/429/oj. (2) Commission Delegated Regulation (EU) 2020/687 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council, as regards rules for the prevention and control of certain listed diseases (OJ L 174, 3.6.2020, p. 64, ELI: http://data.europa.eu/eli/reg_del/2020/687/oj). (3) Commission Implementing Regulation (EU) 2018/1882 of 3 December 2018 on the application of certain disease prevention and control rules to categories of listed diseases and establishing a list of species and groups of species posing a considerable risk for the spread of those listed diseases (OJ L 308, 4.12.2018, p. 21, ELI: http://data.europa.eu/eli/reg_impl/2018/1882/oj). (4) Commission Implementing Decision (EU) 2025/1582 of 29 July 2025 concerning certain emergency measures relating to infection with lumpy skin disease virus in Italy and repealing Implementing Decision (EU) 2025/1318 (OJ L, 2025/1582, 1.8.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1582/oj). (5) Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (OJ L 52, 20.2.2023, p. 1, ELI: http://data.europa.eu/eli/reg_del/2023/361/oj). (6) Commission Implementing Decision (EU) 2025/2424 of 25 November 2025 amending Implementing Decision (EU) 2025/1582 concerning certain emergency measures relating to infection with lumpy skin disease virus in Italy (OJ L, 2025/2424, 28.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2424/oj). (7) https://www.woah.org/en/what-we-do/standards/codes-and- manuals/terrestrial-code-online-access/. * * * ANNEX ‘ANNEX I Protection and surveillance zones established around the confirmed outbreaks Administrative area and ADIS reference number of the outbreak | Areas established as protection and surveillance zones, part of the restricted zone, referred to in Article 1 | Date until applicable ---|---|--- Sardinia region IT-LSD-2025-00001 IT-LSD-2025-00019 IT-LSD-2025-00022 IT-LSD-2025-00037 IT-LSD -2025-00078 | Protection zone: Those parts of the region of Sardinia, contained within a circle of a radius of 20 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 40.30429, Long. 9.22154 (2025/1), Lat. 40.3399, Long. 9.167 (2025/19), Lat. 40.28833, Long. 9.157329 (2025/22), Lat., 40.30125, Long. 9.04641 (2025/37), Lat. 40.090098, Long. 8.720283 (2025/78) | 26.1.2026 Surveillance zone: Those parts of the region of Sardinia, contained within a circle of a radius of 20 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 40.30429, Long. 9.22154 (2025/1), Lat. 40.3399, Long. 9.167 (2025/19), Lat. 40.28833, Long. 9.157329 (2025/22), Lat., 40.30125, Long. 9.04641 (2025/37), Lat. 40.090098, Long. 8.720283 (2025/78) | 27.1.2026 – 12.2.2026 Surveillance zone: Those parts of the region of Sardinia, contained within a circle of a radius of 50 kilometres, centred on UTM 30, ETRS89 coordinates Lat. 40.30429, Long. 9.22154 (2025/1), Lat. 40.3399, Long. 9.167 (2025/19), Lat. 40.28833, Long. 9.157329 (2025/22), Lat., 40.30125, Long. 9.04641 (2025/37), Lat. 40.090098, Long. 8.720283 (2025/78) excluding the areas included in the protection zone. | 12.2.2026 ANNEX II Part A: Vaccination zone II The entire territory of: — | the region of Sardinia until last day of the recovery period, referred to in Part 4 of Annex IX to Delegated Regulation (EU) 2023/361. ---|--- Part B: Vaccination zone I The entire territory of: — | the region of Valle D’Aosta until last day of the recovery period, referred to in Part 4 of Annex IX to Delegated Regulation (EU) 2023/361. ---|--- ’ * * * ELI: http://data.europa.eu/eli/dec_impl/2026/190/oj ISSN 1977-0677 (electronic edition) * * *